Physician

Gaurav Pahouja

According to 2025 Medicare claims, Gaurav Pahouja (NPI: 1760922538) practices urology in the Springfield, OH market, with the plurality of this provider's patient population coming from Clark, OH. This provider's primary affiliated billing organization is SPRINGFIELD UROLOGY LLC (NPI: 1992922025; TIN: 208629620) and primary practice location at 45503-2726. Pahouja is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Pahouja's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 324 traditional Medicare patients, billed 1,739 HCPCS/CPT codes, and received $425,585 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 962 prescription claims across 331 beneficiaries totaling $83,621 in drug costs, led by Gemtesa (Vibegron). Open Payments data shows 36 records totaling $1,338. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,595 and ending at $83,621. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$213K$426K2023 Medicare payment: $15,706 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $425,585 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202360177$15,706
20243241,739$425,585

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$42K$84K2018 Drug cost: $3,595 (USD; Tot_Drug_Cst)2019 Drug cost: $17,736 (USD; Tot_Drug_Cst)2020 Drug cost: $9,410 (USD; Tot_Drug_Cst)2021 Drug cost: $17,592 (USD; Tot_Drug_Cst)2022 Drug cost: $3,451 (USD; Tot_Drug_Cst)2023 Drug cost: $4,372 (USD; Tot_Drug_Cst)2024 Drug cost: $83,621 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018115183$3,595
2019170381$17,736
20204279$9,410
20212959$17,592
20221423$3,451
202372123$4,372
2024331962$83,621

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
52000Diagnostic exam of bladder and urethra using an endoscope6064$132
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more104104$116
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more172299$91
51798Ultrasound measurement of bladder capacity after voiding96141$8
81002Urinalysis, manual test150257$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
GemtesaVibegron481,623$25,297
MyrbetriqMirabegron291,650$24,633
Tamsulosin HclTamsulosin Hcl33120,312$5,040
EstradiolEstradiol441,715$2,201
FinasterideFinasteride988,189$1,162

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.36$1,338Dendreon Pharmaceuticals LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gaurav Pahouja?

Tedicare shows public-source Medicare data for Gaurav Pahouja (NPI 1760922538), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gaurav Pahouja have ACO affiliation data?

Gaurav Pahouja is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Gaurav Pahouja?

Gaurav Pahouja is linked to SPRINGFIELD UROLOGY LLC (billing NPI 1992922025) in the available physician profile data.

Does Gaurav Pahouja have Open Payments data?

Gaurav Pahouja has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.